Dr. Oz Assists After Drug Executive Collapses During Oval Office Briefing
During a press event in the Oval Office on Thursday, a drug executive fainted while President Donald Trump discussed a new agreement with pharmaceutical companies to reduce medication costs.
The incident occurred as representatives from Eli Lilly and Novo Nordisk joined the President to announce expanded access and reduced pricing for popular obesity treatments, including Zepbound and Wegovy.
The Collapse and Immediate Response
According to witnesses, the meeting was interrupted when Gordon Findlay, Novo Nordisk’s global brand director, suddenly collapsed. Dr. Mehmet Oz, Administrator for the Centers for Medicare & Medicaid Services, immediately rushed to assist him.
David Ricks, CEO of Eli Lilly, turned and asked, "Are you okay? Gordon, are you okay?"
Members of the press were then escorted out of the room to allow medical staff to attend to Findlay. Health and Human Services officials were also present when the incident took place.
Health Update and Continuation
Roughly 30 minutes later, the press conference resumed. President Trump informed reporters that Findlay was recovering and in stable condition following the scare. The President emphasized his administration’s efforts to bring down drug costs for American families.
Author’s Summary
During a White House briefing on lowering drug prices, Novo Nordisk’s Gordon Findlay fainted and was aided by Dr. Mehmet Oz; the event later continued after assurances of his recovery.